|Articles|November 16, 2020
- Pharmaceutical Executive-11-01-2020
- Volume 40
- Issue 11
Pharmaceutical Executive, November 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Synthetic Biology and the Environmentover 5 years ago
Measuring Pharma’s Wider Mandateover 5 years ago
Patients as the North Starover 5 years ago
A Rare-Disease Must? Building Long-Term Relationshipsover 5 years ago
Making Remote Work a Success Beyond COVIDover 5 years ago
CRISPR for Diversity, and Humanity’s, Sakeover 5 years ago
Expediting the Cancer Treatment Pathover 5 years ago
Vaccine Authorization, Distribution Raise Multiple Challengesover 5 years ago
EU Leaders in High-Stakes Gamble on COVID ResponsesAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
3
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5